Anticancer agent; microtubule disrupter. Induces apoptosis in human lymphoma cells.
|Storage||Store at -20°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
|Solubility||Soluble to 100 mM in water|
Preparing Stock Solutions
The following data is based on the product molecular weight 923.04. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||1.08 mL||5.42 mL||10.83 mL|
|5 mM||0.22 mL||1.08 mL||2.17 mL|
|10 mM||0.11 mL||0.54 mL||1.08 mL|
|50 mM||0.02 mL||0.11 mL||0.22 mL|
References are publications that support the biological activity of the product.
Jordan et al (1985) Comparison of the effects of vinblastine, vincristine, vindesine, and vinepidine on microtubule dynamics and cell proliferation in vitro. Cancer Res. 45 2741 PMID: 3986806
Takano et al (1993) Apoptosis induced by microtubule disrupting drugs in cultured human lymphoma cells. Inhibitory effects of phorbol ester and zinc sulphate. Pathol.Res.Pract. 189 197 PMID: 8321748
Wang et al (1999) The effect of antimicrotubule agents on signal transduction pathways of apoptosis. Cancer Chemother.Pharmacol. 44 355 PMID: 10501907
If you know of a relevant reference for Vincristine sulfate, please let us know.
Keywords: Vincristine sulfate, Vincristine sulfate supplier, Disrupts, microtubules, Tau, Tubulin, Mitosis, chemotherapeutics, Microtubules, 1257, Tocris Bioscience
7 Citations for Vincristine sulfate
Citations are publications that use Tocris products. Selected citations for Vincristine sulfate include:
Goldman et al (2015) Temporally sequenced anticancer drugs overcome adaptive resistance by targeting a vulnerable chemotherapy-induced phenotypic transition. Nat Commun 6 6139 PMID: 25669750
Zhang (2017) The BTK Inhibitor, Ibrutinib (PCI-32765) Overcomes Paclitaxel Resistance in ABCB1 and ABCC10 Overexpressing Cells and Tumors. Mol Cancer Ther 16 1021 PMID: 28265007
Knutson et al (2014) Synergistic Anti-Tumor Activity of EZH2 Inhibitors and Glucocorticoid Receptor Agonists in Models of Germinal Center Non-Hodgkin Lymphomas. PLoS One 9 e111840 PMID: 25493630
Heinemann et al (2011) Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer. Sci Rep 11 221 PMID: 21645351
Kathawala et al (2014) Masitinib antagonizes ATP-binding cassette subfamily C member 10-mediated paclitaxel resistance: a preclinical study. Mol Cancer Ther 13 714 PMID: 24431074
Torres et al (2016) Adenosine A3 receptor elicits chemoresistance mediated by multiple resistance-associated protein-1 in human glioblastoma stem-like cells. Oncotarget 7 67373 PMID: 27634913
Kathawala et al (2015) The small molecule tyrosine kinase inhibitor NVP-BHG712 antagonizes ABCC10-mediated paclitaxel resistance: a preclinical and pharmacokinetic study. Oncotarget 6 510 PMID: 25402202
Do you know of a great paper that uses Vincristine sulfate from Tocris? Please let us know.
Reviews for Vincristine sulfate
There are currently no reviews for this product. Be the first to review Vincristine sulfate and earn rewards!
Have you used Vincristine sulfate?
Submit a review and receive an Amazon gift card.
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Literature in this Area
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* or download your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.